Market News & Trends
NightstaRx Announces Start of Miami Gene Therapy Study
NightstaRx Ltd recently announced that the Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine, has begun enrolling and dosing subjects…
12th Annual BioProcess International Conference & Exposition Is Largest in Its History
- Global Forum Focused On Advancing Drug Candidates Closer to Approval Faster and More Efficiently Sets Attendance, Exhibitor…
Planbox & Novatek International Announce Exclusive Agile Innovation Partnership for Life Sciences
Planbox has entered into an exclusive worldwide strategic partnership agreement for Planbox Innovate (formerly BrainBank Innovation Management Software), which will be marketed as NOVA-INNOVATE by…
Johnson & JohnsonAnnounces Agreement to Acquire Novira Therapeutics
Johnson & Johnson recently announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment…
First Patient Dosed in Clinical Trial of Halozyme’s Investigational Drug in Combination With Merck’s Immuno-Oncology Drug
Halozyme Therapeutics, Inc. recently announced the first patient has received its investigational new drug, PEGPH20 in combination with Merck's KEYTRUDA (pembrolizumab) in a clinical trial…
FDA Grants Fast-Track Designation for Development of CAM2038, Long-Acting Buprenorphine Injections to Treat Opioid Addiction
Braeburn Pharmaceuticals and Camurus recently announced that the US FDA granted Fast-Track designation for the CAM2038 weekly and monthly buprenorphine subcutaneous injection products under development…
Espero Pharmaceuticals Announces FDA Acceptance of NDA
Espero Pharmaceuticals, Inc., recently announced that the US FDA has accepted for review the New Drug Application (NDA) for GoNitro for acute relief of an…
Xcelience Opens New Headquarters Facility
TAMPA, FLORIDA (October 30, 2015)- Xcelience is proud to announce the grand opening of its new 71,000 square foot headquarters located at 4910 Savarese Circle…
Dow Corning Launches New Portfolio of Topical Ingredients to Help Customers Advance Innovations in Consumer Health Care Applications
Dow Corning, a global leader in silicones, silicon-based technology and innovation, unveiled at the American Association of Pharmaceutical Scientists’ (AAPS) 2015 Annual Meeting and Exhibition…
Celator Pharmaceuticals Announces VYXEOS Shows No QT/QTc Interval Prolongation
Celator Pharmaceuticals, Inc. recently announced that a Phase II pharmacokinetic and pharmacodynamics (PK/PD) study evaluating the effects of VYXEOS (CPX-351) on cardiac depolarization/repolarization has concluded…
Elite Pharmaceuticals Announces Positive Top-Line Results
Elite Pharmaceuticals, Inc. recently announced positive top-line results from the Phase III pivotal trial of its lead opioid abuse-deterrent candidate, ELI-200, for the treatment of…
Honeywell to Acquire Research Chemicals Business From Sigma-Aldrich
Honeywell recently announced it has signed a definitive agreement to acquire the Seelze, Germany-based laboratory research chemicals business from Sigma-Aldrich for approximately 105 million euro.…
EMD Millipore to Provide Provantage End-to-End Solution for Development & Manufacture of Biosimilars Under Strategic Alliance
EMD Millipore recently announced it has entered into a strategic alliance with Turgut Ilaç, a leading biosimilars company based in Turkey and will provide their…
CytoDyn Injects First Patient in Its Current Phase III Study
CytoDyn Inc. recently announced that the first patient in its Phase III clinical trial has been injected with PRO 140, the company's monoclonal antibody for…
BioXcel Initiates Strategic Big Data Partnership With Pronutria
BioXcel Corporation recently announced the initiation of a strategic big data collaboration with Pronutria Biosciences to identify diseases characterized by high unmet need for therapies…
New Jersey Company Seeks Formulation Scientist
Title: Formulation Scientist Position Type: Full-time Department: Research and Development Reports To: Sr. Director of Formulation Effective Date: Ongoing Location: New Jersey Salary: $100K or…
Codexis Earns $6.5-Million Milestone From GSK
Codexis, Inc. recently announced it successfully completed Wave 2 of the transfer of its proprietary CodeEvolver protein engineering platform technology to GlaxoSmithKline (GSK) in the…
Emisphere Signs Lucrative License Agreement With Novo Nordisk
Emisphere Technologies, Inc. recently announced it has entered into a Development and License Agreement with Novo Nordisk A/S to develop and commercialize oral formulations of…
West Launches New Ready-to-Use/Validated Components
West Pharmaceutical Services, Inc. recently launched Daikyo RUV (ready-to-use/validated) components at CPhI Worldwide/InnoPack Europe 2015 in Madrid, Spain. In addition, West is showcasing a range…
Ajinomoto Althea Expands Manufacturing Capabilities to ADC Fill Finish & Bioconjugation
Ajinomoto Althea, Inc. recently announced it is expanding its existing biological drug product manufacturing operations to include highly active materials such as Antibody Drug Conjugates…
